Scholar Rock Holding (SRRK) Common Equity (2017 - 2026)

Scholar Rock Holding (SRRK) recorded quarterly Common Equity of $276.0 million in Q1 2026, up 12.43% quarter-over-quarter from $245.5 million in Q4 2025, and down 11.63% on a YoY basis from $312.3 million in Q1 2025.

Scholar Rock Holding (SRRK) Common Equity (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Common Equity history runs 10 years deep, the most recent figure standing at $276.0 million for Q1 2026.

  • In Q1 2026, Common Equity fell 11.63% year-over-year to $276.0 million; the TTM figure through Mar 2026 stood at $276.0 million (down 11.63% YoY), while the FY2025 annual figure was $245.5 million, down 33.41% from the prior year.
  • Common Equity was $276.0 million for Q1 2026 at Scholar Rock Holding, up from $245.5 million in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $368.6 million in Q4 2024 to a low of $79.2 million in Q3 2024.
  • Historically, Common Equity has averaged $232.6 million across 5 years, with a median of $233.3 million in 2025.
  • The sharpest annual moves came in 2024 and 2025: Common Equity slumped 52.77% in 2024, then soared 209.35% in 2025.
  • A 5-year view of Common Equity shows it stood at $260.2 million in 2022, then dropped by 13.46% to $225.2 million in 2023, then surged by 63.68% to $368.6 million in 2024, then plunged by 33.41% to $245.5 million in 2025, then rose by 12.43% to $276.0 million in 2026.
  • The last three Common Equity figures came in at $276.0 million (Q1 2026), $245.5 million (Q4 2025), and $245.0 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 35.63 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -1.42 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 13.21 Mn
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 14.38 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - 11.87 Mn
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 19.36 Bn
9 Abivax 91.96 Bn 91.96 Bn - -
10 Scholar Rock Holding 6.03 Bn 5.55 Bn - 276.01 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 276.01 Mn
Dec 31, 2025 245.49 Mn
Sep 30, 2025 245.00 Mn
Jun 30, 2025 233.29 Mn
Mar 31, 2025 312.33 Mn
Dec 31, 2024 368.63 Mn
Sep 30, 2024 79.20 Mn
Jun 30, 2024 133.62 Mn
Mar 31, 2024 182.77 Mn
Dec 31, 2023 225.22 Mn
Sep 30, 2023 167.67 Mn
Jun 30, 2023 202.50 Mn
Mar 31, 2023 228.65 Mn
Dec 31, 2022 260.24 Mn
Sep 30, 2022 293.27 Mn
Jun 30, 2022 329.51 Mn
Mar 31, 2022 171.32 Mn
Dec 31, 2021 172.07 Mn
Sep 30, 2021 187.26 Mn
Jun 30, 2021 216.66 Mn